NZZ | The biodiversity of our planet, an important source of inspiration for pharmaceutical breakthroughs, is at a critical point. Its preservation will determine whether the pharmaceutical industry can continue to launch life-saving innovations in the future. Jessica Browning, Pharmaceuticals Strategist at Quantis sat down with NZZ to share insights on how the industry needs to consider biodiversity as a strategic necessity.
Latest resources
How digitalization is unlocking a new era of sustainability in fashion...
While digitalization alone doesn’t guarantee perfect accuracy, it plays a crucial role in many ways like fostering more meaningful supplier engagement, boosting data quality and...
Why an environmental sustainability strategy without nature is incomplete
Businesses have an essential role to play in reversing the trend of nature loss — and a lot to lose from inaction.
Purpose: The 5th ‘P’ in the sustainable food + beverage marketing ...
The 5th 'P' in the marketing mix, purpose, adds depth to product, price, place, and promotion, enabling greater sustainability and impact.
